Chemistry Seminar with Dr. Daniel Thorek from WashU Radiology at 4:00pm

Abstract: Targeted radiopharmaceuticals are an emerging class of agents that combine molecularly specific ligands with isotopes for research and clinical applications. Chemical advances for isotope production, evaluation and bioconjugation have led to several recent FDA approvals and increasing investment in the space. This presentation will focus on the possibilities for theranostics, a portmanteau of diagnostics and therapeutics, that are uniquely actionable using radioisotopes. Using novel approaches to design and test these theranostics in clinically relevant models, we will discuss current challenges and opportunities for further development in this growing field.